|
|
Volumn 59, Issue 4, 2000, Pages 291-292
|
|
Recommendations of the German society for rheumatology for the treatment with TNFα inhibitors: Committee for Pharmacotherapy;Empfehlungen der Deutschen gesellschaft fur rheumatologie zur therapie mit tumornekrosefaktor-hemmenden substanzen: Kommission pharmakotherapie der Deutschen gesellschaft fur rheumatologie
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
UNCLASSIFIED DRUG;
ANTIRHEUMATIC AGENT;
DRUG MECHANISM;
GERMANY;
HUMAN;
IMMUNOMODULATION;
IMMUNOTHERAPY;
JUVENILE RHEUMATOID ARTHRITIS;
RHEUMATIC DISEASE;
RHEUMATOID ARTHRITIS;
SCORING SYSTEM;
SHORT SURVEY;
TREATMENT CONTRAINDICATION;
TREATMENT INDICATION;
ARTICLE;
DRUG ANTAGONISM;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
GERMANY;
HUMANS;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 0033817392
PISSN: 03401855
EISSN: None
Source Type: Journal
DOI: 10.1007/s003930070070 Document Type: Short Survey |
|
Times cited : (9)
|
|
References (0)
|